Pfizer will end development of daily weight-loss pill after liver injury Pfizer is facing another setback with its weight-loss pill, danuglipron. The pharmaceutical giant stopped development of the drug after liver issues affected one patient. Orignial Source: https://www.foxbusiness.com/lifestyle/pfizer-end-development-daily-weight-loss-pill-after-liver-injury Previous article: Unemployment worries jump to highest level since 2020 in New York Fed survey Prev Next article: Blue Origin launches Katy Perry, all-female crew into space, completes safe landing Next
